Transarterial Chemoembolization Combined With Apatinib for Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis

Background: Apatinib is a powerful inhibitor of vascular endothelial growth factor receptor-2. This study was aimed to investigate whether apatinib could improve the efficacy of transarterial chemoembolization (TACE) in patients with advanced hepatocellular carcinoma (HCC). Methods: Between June 201...

Descripción completa

Detalles Bibliográficos
Autores principales: Kan, Xuefeng, Liang, Bin, Zhou, Guofeng, Xiong, Bin, Pan, Feng, Ren, Yanqiao, Cao, Yanyan, Wang, Jihua, Yang, Fan, Zheng, Chuansheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7358575/
https://www.ncbi.nlm.nih.gov/pubmed/32733791
http://dx.doi.org/10.3389/fonc.2020.00970

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7358575/
https://www.ncbi.nlm.nih.gov/pubmed/32733791
http://dx.doi.org/10.3389/fonc.2020.00970

Ejemplares similares